Bevacizumab boosts INF-α-2a in metastatic renal cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab + INF-α-2a: safer and therefore less costly in mRCC

Reactions Weekly, Vol. 1, Iss. 1329, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

PEG INF-α-2a/ribavirin cost effective for mild-chronic hep C

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Bevacizumab boosts chemotherapy response in breast cancer

Inpharma, Vol. 1, Iss. 1377, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Gemcitabine boosts paclitaxel efficacy in metastatic breast cancer

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Management of Metastatic Renal Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 1, 2005-01 ,pp. : 105-113

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite